Connect Sign In
ARUP is the first U.S. lab to validate Rarity Bioscience’s ultrasensitive superRCA™ assay, which advances high-precision mutation detection and supports innovation in clinical and trial settings.
The Winter 2026 Edition of ARUP’s Magnify Magazine Is Now Available and Focuses on Pediatric Testing
ARUP has built a comprehensive pediatric test menu and paired it with research, education, and expert consultation to help care teams make informed decisions for children.
New ADLM guidance helps emergency department providers choose and interpret urine drug tests, highlighting current methods, limitations, and recommended drug classes.
During Cervical Cancer Awareness Month, ARUP Consult® highlights self-collected vaginal specimen testing as an FDA-approved, guideline-supported option to help address HPV screening barriers.
ARUP Laboratories’ dual-target molecular measles virus assay provides a highly sensitive, specific, and rapid assay to aid the public health response to ongoing measles outbreaks.
James Hadley, CISSP, chief information security officer, brings 25 years of cybersecurity experience to ARUP with a focus on risk management, collaboration, and building a resilient security culture.
In his new role, Adam Barker, PhD, will lead operational innovation to support ARUP’s growth while maintaining the highest quality.
RIDGEWATER, N.J.—Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders…
Tracy George, MD, ARUP chief scientific officer and Innovation Business Unit president, will help advance life sciences innovation and strengthen Utah’s healthcare ecosystem with BioUtah.
ARUP experts will showcase their latest research at the ASH Annual Meeting and Exposition, including updates on key clinical trials and the development of automated disease scoring.
Paul’s life was saved thanks to 12 generous blood donors, demonstrating the power of community and compassion.
ARUP Advocates for the RESULTS Act To Protect Patient Access to Critical Laboratory Testing Services
The RESULTS Act offers meaningful reform to a flawed system and will ultimately benefit patients, support innovation, and create stability within the clinical laboratory community.
